112 related articles for article (PubMed ID: 5407060)
1. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
Matsushima T; Weisburger JH
Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
[No Abstract] [Full Text] [Related]
2. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
Barry EJ; Gutmann HR
Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
[No Abstract] [Full Text] [Related]
3. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
Barry EJ; Malejka-Giganti D; Gutmann HR
Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
[No Abstract] [Full Text] [Related]
4. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat.
Weisburger JH; Yamamoto RS; Williams GM; Grantham PH; Matsushima T; Weisburger EK
Cancer Res; 1972 Mar; 32(3):491-500. PubMed ID: 5061304
[No Abstract] [Full Text] [Related]
5. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo.
Kriek E
Chem Biol Interact; 1969 Oct; 1(1):3-17. PubMed ID: 5407054
[No Abstract] [Full Text] [Related]
6. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide.
Grantham PH; Weisburger JH; Weisburger EK
Food Cosmet Toxicol; 1973 Apr; 11(2):209-17. PubMed ID: 4716799
[No Abstract] [Full Text] [Related]
7. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
Kriek E
Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
[No Abstract] [Full Text] [Related]
8. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro.
Gutmann HR; Erickson RR
J Biol Chem; 1972 Feb; 247(3):660-6. PubMed ID: 5058220
[No Abstract] [Full Text] [Related]
9. Inhibition of rat liver ribonucleic acid polymerase by the carcinogen N-hydroxy-2-fluorenylacetamide.
Zieve FJ
J Biol Chem; 1972 Sep; 247(18):5987-95. PubMed ID: 5057094
[No Abstract] [Full Text] [Related]
10. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
Levine WG
Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
[No Abstract] [Full Text] [Related]
11. Preferential binding of 2-acetylaminofluorene to rat liver rRNA during early stages of hepatocarcinogenesis.
Irving CC; Veazey RA
Biochem Biophys Res Commun; 1972 Jun; 47(5):1159-64. PubMed ID: 5029863
[No Abstract] [Full Text] [Related]
12. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Yost Y; Gutmann HR; Rydell RE
Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
[TBL] [Abstract][Full Text] [Related]
13. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
[No Abstract] [Full Text] [Related]
14. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
Irving CC; Peeler TC; Veazey RA; Wiseman R
Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
[No Abstract] [Full Text] [Related]
15. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
Gutmann HR; Erickson RR
J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
[No Abstract] [Full Text] [Related]
16. Effects of the carcinogen N-acetoxy-2-fluorenylacetamide on the template properties of deoxyribonucleic acid.
Zieve FJ
Mol Pharmacol; 1973 Sep; 9(5):658-69. PubMed ID: 4363017
[No Abstract] [Full Text] [Related]
17. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
Zieve FJ; Gutmann HR
Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
[No Abstract] [Full Text] [Related]
18. Activities of the carcinogen N-hydroxy-2-fluorenylacetamide: insensitivity to cyanide and sulfide of the peroxidase-H202 induced formation of nucleic acid adducts.
King CM; Bednar TW; Linsmaier-Bednar EM
Chem Biol Interact; 1973 Sep; 7(3):185-8. PubMed ID: 4768577
[No Abstract] [Full Text] [Related]
19. Effect of acetanilide and p-hydroxyacetanilide on the carcinogenicity of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters, and female rats.
Weisburger JH; Weisburger EK; Madison RM; Wenk ML; Klein DS
J Natl Cancer Inst; 1973 Jul; 51(1):235-40. PubMed ID: 4720874
[No Abstract] [Full Text] [Related]
20. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
Witschi H; Epstein SM; Farber E
Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
